Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Shares Issued (2024)

Caris Life Sciences (CAI) has 1 years of Shares Issued data on record, last reported at $524.7 million in Q4 2025.

  • For Q4 2025, Shares Issued changed N/A year-over-year to $524.7 million; the TTM value through Dec 2025 reached $518.2 million, changed N/A, while the annual FY2025 figure was $528.5 million, N/A changed from the prior year.
  • Shares Issued reached $524.7 million in Q4 2025 per CAI's latest filing, up from -$6.5 million in the prior quarter.
  • Across five years, Shares Issued topped out at $524.7 million in Q4 2025 and bottomed at -$6.5 million in Q3 2025.